Dynamics of insulin signaling in 3T3-L1 adipocytes - Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2

被引:143
作者
Inoue, G
Cheatham, B
Emkey, R
Kahn, CR
机构
[1] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA
关键词
D O I
10.1074/jbc.273.19.11548
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability of the insulin receptor to phosphorylate multiple substrates and their subcellular localization are two of the determinants that contribute to diversity of signaling, We find that insulin receptor substrate (IRS)-1 is 2-fold more concentrated in the intracellular membrane (IM) compartment than in cytosol, whereas IRS-2 is 2-fold more concentrated in cytosol than in IM. Insulin stimulation induces rapid tyrosine phosphorylation of both IRS-1 and IRS-2. This occurs mainly in the IM compartment, even though IRS-S is located predominantly in cytosol, Furthermore, after insulin stimulation, both IRS-1 and IRS-2 translocate from IRI to cytosol with a t(1/2) of 3.5 min. Using an in vitro reconstitution assay, we have demonstrated an association between IRS-1 and internal membranes and have shown that the dissociation of IRS-1 from IM is dependent on serine/ threonine phosphorylation of IM. By comparison, within 1 min after insulin stimulation, 40% of the total pool of the 85-kDa subunit of phosphatidylinositol 3-kinase (p85) is recruited from cytosol to IM, the greater part of which can be accounted for by binding to IRS-1 present in the IM. The p85 binding and phosphatidylinositol 3-kinase activity associated with IRS-2 rapidly decrease in both IM and cytosol, whereas those associated with IRS-1 stay at a relatively high level in IM and increase with time in cytosol despite a return of p85 to the cytosol and decreasing tyrosine phosphorylation of cytosolic IRS-1. These data indicate that IRS-1 and IRS-2 are differentially distributed in the cell and move from IRI to cytosol following insulin stimulation. Insulin-stimulated IRS-1 and IRS-S signaling occurs mainly in the IM and shows different kinetics; IRS-l-mediated signaling is more stable, whereas IRS-a-mediated signaling is more transient. These differences in substrate utilization and compartmentalization may contribute to the complexity and diversity of the insulin signaling network.
引用
收藏
页码:11548 / 11555
页数:8
相关论文
共 36 条
  • [1] Mechanism of activation of protein kinase B by insulin and IGF-1
    Alessi, DR
    Andjelkovic, M
    Caudwell, B
    Cron, P
    Morrice, N
    Cohen, P
    Hemmings, BA
    [J]. EMBO JOURNAL, 1996, 15 (23) : 6541 - 6551
  • [2] Antonetti DA, 1996, MOL CELL BIOL, V16, P2195
  • [3] The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS - Modulation by insulin growth factor-1 (IGF) and enhanced IGF-1 signaling
    BeitnerJohnson, D
    Blakesley, VA
    ShenOrr, Z
    Jimenez, M
    Stannard, B
    Wang, LM
    Pierce, J
    LeRoith, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) : 9287 - 9290
  • [4] BERGERING BM, 1995, NATURE, V376, P599
  • [5] Bruning JC, 1997, MOL CELL BIOL, V17, P1513
  • [6] PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION IS REQUIRED FOR INSULIN STIMULATION OF PP70 S6 KINASE, DNA-SYNTHESIS, AND GLUCOSE-TRANSPORTER TRANSLOCATION
    CHEATHAM, B
    VLAHOS, CJ
    CHEATHAM, L
    WANG, L
    BLENIS, J
    KAHN, CR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) : 4902 - 4911
  • [7] CLANCY BM, 1990, J BIOL CHEM, V265, P12434
  • [8] Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor
    Eck, MJ
    DhePaganon, S
    Trub, T
    Nolte, RT
    Shoelson, SE
    [J]. CELL, 1996, 85 (05) : 695 - 705
  • [9] THE PROTEIN-KINASE ENCODED BY THE AKT PROTOONCOGENE IS A TARGET OF THE PDGF-ACTIVATED PHOSPHATIDYLINOSITOL 3-KINASE
    FRANKE, TF
    YANG, SI
    CHAN, TO
    DATTA, K
    KAZLAUSKAS, A
    MORRISON, DK
    KAPLAN, DR
    TSICHLIS, PN
    [J]. CELL, 1995, 81 (05) : 727 - 736
  • [10] Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
    Franke, TF
    Kaplan, DR
    Cantley, LC
    Toker, A
    [J]. SCIENCE, 1997, 275 (5300) : 665 - 668